Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China
Related Posts
Tang AB, Li S, Li Y, Zhao J, Thomas K, Lewsey SC, Heidenreich PA, Greene SJ, Allen LA, Jessup M, Bolles M, Rutan C, Navar[...]
Karpouzas GA, Cosedis Enevoldsen F, Rezaeian P, Masic D, Budoff MJ, Hauge EM, Ormseth SR. Pericoronary fat attenuation and its association with atherosclerosis in rheumatoid[...]
Mounsey LA, Alotaibi M, Parekh JK, Nemeth SM, McNeill JN, Cheng S, Jain M, Lewis GD, Ho JE. Transpulmonary eicosanoid metabolite gradients: insights into metabolic[...]